Dicerna Pharmaceuticals
DRNA
#4014
Rank
S$3.84 B
Marketcap
S$49.30
Share price
0.00%
Change (1 day)
17,042.30%
Change (1 year)

Earnings for Dicerna Pharmaceuticals (DRNA)

Earnings in 2021 (TTM): -S$0.16 Billion

According to Dicerna Pharmaceuticals's latest financial reports the company's current earnings are S$0.19 Billion. In 2020 the company made an earning of -S$0.14 Billion, an increase over its 2019 earnings that were of -S$0.16 Billion.

Earnings history for Dicerna Pharmaceuticals from 2013 to 2021

Annual earnings

Year Earnings Change
2021 (TTM)-S$0.16 Billion12.85%
2020-S$0.14 Billion-11.52%
2019-S$0.16 Billion38.33%
2018-S$0.12 Billion46.14%
2017-S$78.16 Million1.8%
2016-S$76.78 Million-5.58%
2015-S$81.31 Million32.01%
2014-S$61.59 Million171.79%
2013-S$22.67 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
S$8.98 B-6,022.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$14.25 B-9,493.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$8.67 B-5,814.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
-S$61.19 Million-59.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
S$1.57 B-1,138.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
-S$0.21 Billion 35.54%๐Ÿ‡บ๐Ÿ‡ธ USA